Latest Press Releases

Health News Posted on Monday, July 28, 2025

Premium Press Releases »

Zero Waiting Period in Health Insurance What You Need to Know

Because your health doesn’t wait, and neither should your policy. Highlights: Health insurance typically comes with a waiting period before certain conditions are covered Zero waiting period means you can get coverage for select treatments ...

Read More

First half of 2025: Solid growth, Investments and Pipeline Progress Pave the Way for Two Key Launches in H2

Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion) Regulatory submissions underway for zongertinib and nerandomilast, with launches expected in H2 2025 Strategic ...

Read More

Press Releases »

NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer

PR Newswire HONG KONG, July 28, 2025 HONG KONG, July 28, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the National Medical Products Administration (NMPA) has accepted the supplementary New ...

Read More
Advertisement

Ascletis Announces First Participants with Obesity or Overweight Dosed in Its U.S. 12-week Phase IIa Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small Molecule GLP-1R Agonist ASC30

PR Newswire HONG KONG, July 27, 2025 -          First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot ...

Read More

Elpis Biopharmaceuticals Signs Memorandum of Understanding with National Cancer Centre Singapore to Conduct Translational Cell Therapy Research in Singapore

PR Newswire SINGAPORE and LEXINGTON, Mass., July 27, 2025 Collaboration focuses on advancing clinically validated armored CAR technologies into first-in-human trials in Singapore and accelerate translational research from bench-to-bedside ...

Read More

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: DECADES-OLD LEAD POLLUTION LINKED TO MEMORY PROBLEMS IN OLDER ADULTS, STUDY FINDS

PR Newswire TORONTO, July 27, 2025 Key Takeaways TORONTO, July 27, 2025 /PRNewswire/ -- Historic lead levels from the era of leaded gasoline may be contributing to cognitive issues 50 years later, suggests research reported for the first ...

Read More
Advertisement

Zero Waiting Period in Health Insurance What You Need to Know

Because your health doesn’t wait, and neither should your policy. Highlights: Health insurance typically comes with a waiting period before certain conditions are covered Zero waiting period means you can get coverage for select treatments ...

Read More

NAMI Statement on Executive Order Targeting Homelessness and Criminalizing Mental Illness

PR Newswire ARLINGTON, Va., July 25, 2025 ARLINGTON, Va., July 25, 2025 /PRNewswire/ -- Yesterday, the White House released a new Executive Order, "Ending Crime and Disorder on America's Streets," which directs federal agencies to make it ...

Read More

New Teeth Chicago Dental Implant Center Offers Lifeline to Abandoned Implant Patient in Chicago.

PR Newswire CHICAGO, July 25, 2025 New Teeth Chicago Dental Implant Center and Dr. Irfan Atcha steps in to take over dental implant treatment of abandoned patients from the closed corporate dental implant centers in Chicagoland area. ...

Read More

Proteomics Market to Expand Rapidly, with 13% CAGR forecast Through 2030

PR Newswire BOSTON, July 25, 2025 "Advances in proteomics technologies are driving growth in precision medicine, with rising demand for early diagnostics, personalized therapies, and deeper insights into disease mechanisms." BOSTON, July ...

Read More

Healthcare Analytical Testing Services Market worth $12.48 billion by 2030 with 10.8% CAGR | MarketsandMarketsâ„¢

PR Newswire DELRAY BEACH, Fla., July 25, 2025 DELRAY BEACH, Fla., July 25, 2025 /PRNewswire/ -- The global Healthcare Analytical Testing Services Market, valued at US$6.33 billion in 2024 stood at US$7.48 billion in 2025 and is projected to ...

Read More

Children's Hospital of Philadelphia Researchers Analyze Best Methods to Minimize Risk of Pediatric Vehicular Heatstroke

PR Newswire PHILADELPHIA, July 25, 2025 A combination of interventions is optimal to prevent children from dying in overheated cars PHILADELPHIA, July 25, 2025 /PRNewswire/ -- Different technologies have been developed to help parents ...

Read More

Spear Bio Launches Next Generation Ultrasensitive Immunoassay Solution SPEAR UltraDetectâ„¢ to Transform Neurodegenerative Disease Research

PR Newswire WOBURN, Mass., July 25, 2025 WOBURN, Mass., July 25, 2025 /PRNewswire/ -- Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, today announced the commercial launch of its SPEAR ...

Read More

IceCure's ProSense® Featured at Japanese Breast Cancer Society Conference: Updated Positive Clinical Data Shows 99% Recurrence Free Rate with Cryoablation

PR Newswire CAESAREA, Israel, July 25, 2025 Breast surgeon, Professor Eisuke Fukuma, a highly regarded cryoablation expert & ProSense® user at Kameda Medical Center, presented updated breast cancer cryoablation data from an independent study ...

Read More

Sen-Jam Pharmaceutical Advances First-in-Class FDA Hangover Prevention Therapy, SJP-001, to Phase 2 Trials in Canada

PR Newswire HUNTINGTON, N.Y., July 25, 2025 Cliantha Research spearheads clinical study as growing evidence and investor enthusiasm converge around inflammation-based innovation. HUNTINGTON, N.Y., July 25, 2025 /PRNewswire/ -- Sen-Jam ...

Read More

Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

PR Newswire INDIANAPOLIS, July 25, 2025 INDIANAPOLIS, July 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc. (Nasdaq: VERV). Verve is a ...

Read More

Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint

PR Newswire SUZHOU, China, July 25, 2025 SUZHOU, China, July 25, 2025 /PRNewswire/ -- The Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed ...

Read More

From Survival to Self-Mastery in 90 Days: New Program Helps Women Stop Self-Abandoning and Rise into High-Value Leadership

PR Newswire TORONTO, July 25, 2025 Elaine Yuen Healer Inc. introduces a 13-week coaching program that helps high-achieving women over 30 build confidence, master emotional intelligence, and reconnect with their intuition to bridge the ...

Read More

Servier Receives Positive CHMP Opinion for VORANIGO® (vorasidenib) for the Treatment of Adults and Adolescents with Grade 2 IDH-mutant Diffuse Glioma

PR Newswire BOSTON, July 25, 2025 BOSTON, July 25, 2025 /PRNewswire/ -- Servier today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending ...

Read More

Taiho Oncology Announces Acceptance of Abstract for Zipalertinib at the ESMO Congress 2025

PR Newswire PRINCETON, N.J., July 25, 2025 PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced it will ...

Read More

Shoppers Foundation for Women's Health launches in-store period product donation drive to promote menstrual equity

Canada NewsWire TORONTO, July 25, 2025 Support local women's shelters and food banks via the Pad It Forward campaign TORONTO, July 25, 2025 /CNW/ - Shoppers Foundation for Women's Healthâ„¢ is inviting Canadians to join them in their fight ...

Read More

Donanemab receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in early symptomatic Alzheimer's disease

PR Newswire INDIANAPOLIS, July 25, 2025 The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today ...

Read More

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

PR Newswire LAS VEGAS, July 24, 2025 The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of rheumatoid ...

Read More

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

PR Newswire LAS VEGAS, July 24, 2025 The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses, growing awareness of the B7-H4 biomarker, and ...

Read More

LeadingAge partners with ICAA for Active Aging Week 2025: Celebrating the contributions and spirit of older adults

PR Newswire VANCOUVER, BC, July 24, 2025 The International Council on Active Aging® (ICAA) has announced a new partnership with LeadingAge to expand the reach of Active Aging Week 2025, presented by Humana. Taking place October 6–12, this ...

Read More

LUNGevity Foundation Joins 2025 LungXperience Tour to Promote Lung Health and Early Detection Across the U.S.

PR Newswire WASHINGTON, July 24, 2025 Organization to Participate in 12 National Events as Part of Innovative Health Education Initiative WASHINGTON, July 24, 2025 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung ...

Read More

Akeso Announces First Patient Enrollment in Phase III Trial of Ivonescimab for Pancreatic Cancer

PR Newswire HONG KONG, July 23, 2025 HONG KONG, July 23, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical ...

Read More

Happy Docs Make Happy Patients

PR Newswire ST. LOUIS, July 23, 2025 AI technology boosts face-to-face time with patients, earns Mercy national recognition for physician satisfaction ST. LOUIS, July 23, 2025 /PRNewswire/ -- Mercy's strategic and carefully planned use ...

Read More

Scaling Self-Care Can Be a Game-Changer in Global Fight Against Non-Communicable Diseases

PR Newswire GENEVA, July 24, 2025 GENEVA, July 24, 2025 /PRNewswire/ -- On International Self-Care Day, and as world leaders prepare for a landmark United Nations General Assembly meeting on non-communicable diseases (NCDs) this September, ...

Read More

Hillhurst Biopharmaceuticals Doses First Subject in Phase 2a Clinical Trial of HBI-002, a Novel Therapy for Sickle Cell Disease

PR Newswire SAN DIEGO, July 23, 2025 SAN DIEGO, July 23, 2025 /PRNewswire/ -- Hillhurst Biopharmaceuticals Inc. ("Hillhurst"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products based on known ...

Read More

Blenrep (belantamab mafodotin) combinations approved in Canada for the treatment of relapsed/refractory multiple myeloma

Canada NewsWire MISSISSAUGA, ON, July 23, 2025 MISSISSAUGA, ON, July 23, 2025 /CNW/ - GSK announced today that Health Canada has approved Blenrep (belantamab mafodotin for injection) in combination with bortezomib and dexamethasone, or in ...

Read More

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertasâ„¢ Wearable Injector Technology for Biologic Drugs

PR Newswire FRANKLIN LAKES, N.J., July 23, 2025 FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...

Read More
More Press Releases